Identification | More | [Name]
5-Bromo-2-chloro-3-nitropyridine | [CAS]
67443-38-3 | [Synonyms]
2-PYRIDINECARBOXYLIC ACID, 5-BROMO- 5-BROMO-2-CARBOXYPYRIDINE 5-BROMO-2-CHLORO-3-NITROPYRIDINE 5-BROMO-2-PICOLINIC ACID 5-BROMO-2-PYRIDINECARBOXYLIC ACID 5-BROMOPICOLINIC ACID 5-BROMOPYRIDINE-2-CARBOXYLIC ACID IFLAB-BB F1957-0001 RARECHEM AL BO 2390 2-Chloro-3-nitro-5-bromopyridine 2-CHLORO-5-BROMO-3-NITROPYRIDINE 5-BROMO-2-CHLORO-3-NITROPYRIDINE 98% | [EINECS(EC#)]
675-866-1 | [Molecular Formula]
C5H2BrClN2O2 | [MDL Number]
MFCD00234149 | [Molecular Weight]
237.44 | [MOL File]
67443-38-3.mol |
Chemical Properties | Back Directory | [Appearance]
Light yellow powder | [Melting point ]
65-70 °C | [Boiling point ]
285.4±35.0 °C(Predicted) | [density ]
1.936±0.06 g/cm3(Predicted) | [storage temp. ]
Keep in dark place,Sealed in dry,Room Temperature | [solubility ]
DMSO, Methanol | [form ]
Crystalline Powder | [pka]
-4.99±0.10(Predicted) | [color ]
Yellow | [InChI]
InChI=1S/C5H2BrClN2O2/c6-3-1-4(9(10)11)5(7)8-2-3/h1-2H | [InChIKey]
WWQQPSDIIVXFOX-UHFFFAOYSA-N | [SMILES]
C1(Cl)=NC=C(Br)C=C1[N+]([O-])=O | [CAS DataBase Reference]
67443-38-3(CAS DataBase Reference) |
Safety Data | Back Directory | [Hazard Codes ]
Xn,Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . R21/22:Harmful in contact with skin and if swallowed . | [Safety Statements ]
S37/39:Wear suitable gloves and eye/face protection . S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . | [RIDADR ]
2811 | [WGK Germany ]
3 | [Hazard Note ]
Harmful | [HazardClass ]
6.1 | [HazardClass ]
IRRITANT, IRRITANT-HARMFUL | [PackingGroup ]
Ⅲ | [HS Code ]
29333990 |
Raw materials And Preparation Products | Back Directory | [Raw materials]
Sulfuric acid-->Nitric acid-->Phosphorus oxychloride-->Sodium nitrite-->Phosphorus pentachloride-->2-Amino-5-bromopyridine-->2(1H)-PYRIDINONE, 5-BROMO-3-NITRO-, MONOHYDROBROMIDE-->2-Hydroxy-5-bromopyridine-->2-Amino-5-bromo-3-nitropyridine-->5-Bromo-3-nitro-2-pyridinol | [Preparation Products]
2,4-difluoro-N-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)benzenesulfonamide-->5-BROMO-2-METHOXY-3-NITRO-PYRIDINE-->4-bromo-6-methyl-1-tosyl-1H-pyrrolo[2,3-c]pyridin-7(6H)-one-->N-(5-bromo-2-methoxypyridin-3-yl)-2,4-difluorobenzenesulfonamide-->6-Bromo-4-aza-2-oxindole |
Hazard Information | Back Directory | [Chemical Properties]
Light yellow powder | [Uses]
5-Bromo-2-chloro-3-nitropyridine is used as pharmaceutical intermediate. | [Synthesis]
The general procedure for the synthesis of 2-chloro-3-nitro-5-bromopyridine from 2-amino-3-nitro-5-bromopyridine was as follows: 2-amino-5-bromo-3-nitropyridine (21.8 g, 0.1 mol) was ground in a mortar and pestle to a fine powder, which was subsequently suspended in 6 M hydrochloric acid (250 ml). The mixture was cooled to 0 °C and solid NaNO2 (8.3 g, 0.12 mol) was slowly added while keeping the internal temperature below 5 °C (about 45 min). After addition, stirring was continued at 0 °C for 1 hour. To the resulting suspension was added a solution of freshly prepared copper(I) chloride (12.9 g, 0.13 mol) dissolved in degassed 38% hydrochloric acid, and the reaction mass was gradually warmed up to room temperature over 90 min, and then subsequently heated up to 70°C to complete the decomposition of the diazonium salt. The reaction mixture was cooled, diluted with water (750 ml), passed through air for 30 min, and the pH was subsequently adjusted by the addition of 0.88 ammonia to about 9. The blue mixture was mixed with ether (600 ml) and shaken, and the insoluble solids were removed by filtration. The organic layer was washed sequentially with 5% ammonia, water, and brine and dried with anhydrous sodium sulfate. After filtration, the solution was pre-adsorbed onto silica and purified by fast chromatography using a gradient elution of isohexane with 5% to 20% ethyl acetate to afford 5-bromo-2-chloro-3-nitropyridine as a light yellow solid (13.1 g, 55% yield) and to recover the starting material (6.4 g). The structure of the product was confirmed by 1H NMR (400 MHz, CDCl3): δ 8.36 (1H, d, J=1Hz, H-6), 8.69 (1H, d, J=1Hz, H-4). | [References]
[1] Patent: WO2007/129044, 2007, A1. Location in patent: Page/Page column 77 [2] Patent: EP1214319, 2003, B1. Location in patent: Page/Page column 13 [3] Journal of Heterocyclic Chemistry, 2003, vol. 40, # 2, p. 261 - 268 [4] Journal of the Chemical Society, 1952, p. 2042,2044 [5] Journal of the Chemical Society, 1952, p. 2042,2044 |
|
|